electroCore, Inc. ECOR
Biotechnology: Electromedical & Electrotherapeutic Apparatus · IPO 2018 · data as of November 13, 2026
electroCore, Inc. (ECOR) is a healthcare company listed in the US with a market value of about $48M. In the twelve months to September 30, 2026 it had revenue of $38M and net income of -$13M, a net margin of -33.5%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (4/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 56% a year, a 5-year average ROIC of -125%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 37% below the current price.
About electroCore
electroCore is listed in the US and classified in biotechnology: electromedical & electrotherapeutic apparatus, IPO year 2018. Revenue went from $811457 in 2017 to $32M in 2025, growth of about 58.3% a year. It was profitable in 0 of the last 9 years in our data. Its share count rose by 79% over three years (dilution for shareholders).
Score: 1.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- Strong R&D investment or growth above 20%
- 5-year revenue growth above 8% a year
- ROE above 15%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year free cash flow growth above 10% a year
- 5-year EPS growth above 10% a year
- 5-year average ROIC above 12%
Valuation
Growth and quality
Financials, last 9 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $32M | $25M | $16M | $9M | $5M | $3M | $2M | $992953 | $811457 |
| Net income | -$13M | -$14M | -$12M | -$19M | -$22M | -$17M | -$24M | -$45M | -$56M | -$36M |
| Free cash flow | -$11M | -$8M | — | -$15M | — | — | — | -$45M | -$47M | -$25M |
| EPS (diluted) | $-1.39 | $-1.65 | $-1.59 | $-3420.00 | $-4.69 | $-4.36 | $-0.60 | $-1.54 | $-1.19 | — |
| Net margin | -33.5% | -43.6% | -47.2% | -117.5% | -257.9% | -315.9% | -672.6% | -1888.8% | -5621.7% | -4410.9% |
| ROIC | — | -117.4% | -103.3% | -229.5% | -124.3% | -51.0% | -91.2% | -139.1% | -61.8% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is electroCore stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 37% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does electroCore pay a dividend?
Not currently.
Is electroCore a good stock to buy?
We do not give buy or sell advice. electroCore scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.